Introduction
Contrast-enhanced US (CEUS) has evolved from its early clinical use in echocardiography and focal liver lesion characterization into a broader technique for evaluating organ perfusion and vascular integrity. Nonhepatic applications now include trauma, vascular complications, renal and bowel imaging, and image-guided interventions. Contemporary reviews and guidelines recognize CEUS as a problem-solving modality in selected acute and point-of-care settings.1-3
US contrast agents consist of gas-filled microbubbles approximately the size of erythrocytes that remain confined to the intravascular space. When insonated, microbubbles oscillate nonlinearly, and contrast-specific pulse sequences suppress the predominantly linear tissue signal while preserving the nonlinear microbubble response. Imaging at a low mechanical index minimizes microbubble destruction and allows continuous observation of arterial arrival and parenchymal enhancement. Because the signal reflects circulating microbubbles independent of the insonation angle, CEUS is sensitive to microvascular perfusion that may be inapparent on conventional color or power Doppler.4-6 Unlike CT or MRI, CEUS depicts contrast transit in real time at the bedside and can be repeated without ionizing radiation or nephrotoxicity.
Point-of-care US has transformed acute and critical care through rapid anatomic and macrovascular assessment, but many time-sensitive questions are fundamentally physiologic: Is an organ perfused? Is blood escaping the vascular space? Has inflammation altered regional microvascular flow? CT remains the reference standard for many acute abnormalities, particularly when a comprehensive field of view is required, but CEUS can address selected perfusion questions in real time at the bedside without ionizing radiation or nephrotoxic contrast.1,7,8 This review focuses on recurring perfusion patterns across organ systems and how these patterns apply to acute care cases.
Why Perfusion Matters at the Point of Care
Acute US imaging traditionally focuses on morphology, including mural thickening, focal lesions, and fluid collections. Many time-sensitive diagnoses, however, are fundamentally disorders of tissue perfusion. In the acute setting, CEUS findings can be organized into 3 recurring patterns that apply across organ systems and clinical scenarios (Table 1): reduced perfusion associated with ischemia, infarction, and devascularizing injury; misdirected perfusion, characterized by extravascular contrast accumulation associated with hemorrhage; and increased perfusion associated with inflammation and infection.
| Perfusion Pattern | Contrast-Enhanced US Signature | Representative Emergent Diagnoses | Management Consequence |
|---|---|---|---|
| Reduced | Ischemia: slow/hypoenhancement Infarction: Well-demarcated, persistent nonenhancement across all phases | Splenic/renal/hepatic infarct; testicular torsion; pulmonary infarction | Confirms nonviability; drives urgent surgery (torsion) or supportive care |
| Misdirected | Microbubble pooling or pulsatile jet beyond vascular architecture; contained to-and-fro pattern (pseudoaneurysm) | Active solid-organ hemorrhage; pseudoaneurysm | Identifies need for embolization or operative control |
| Increased | Earlier or more intense enhancement than adjacent tissue | Complicated acute cholecystitis; active inflammatory bowel disease | Supports assessment of inflammatory activity and identifies progression toward ischemia, necrosis, or other complications |
These patterns can also be demonstrated with CT and MRI. Unlike CT, which captures isolated phases of contrast enhancement, CEUS allows direct observation of evolving processes such as active hemorrhage, tissue ischemia, and inflammatory hyperemia. Compared with Doppler techniques, which depend on flow direction and insonation angle, CEUS is more sensitive to microvascular perfusion.4-6 The examination can be performed in the emergency department, ICU, or other acute-care settings without transporting the patient.1,7,8 This makes CEUS a monitoring tool as well as a diagnostic modality.
In practical terms, a nonenhancing region suggests infarction or traumatic devascularization, contrast outside the vascular compartment indicates hemorrhage, and focal hyperenhancement reflects inflammatory or infectious hyperemia.
Reduced Perfusion: Ischemia, Injury, and Infarction
Loss of tissue perfusion is one of the most recognizable CEUS findings in acute care. Viable parenchyma enhances promptly following microbubble arrival, whereas ischemic or devascularized tissue remains nonenhancing. On CEUS, this typically appears as a sharply demarcated perfusion defect that is often more obvious than on grayscale or Doppler imaging.9-11
When caused by occlusion of a segmental arterial branch, the defect is classically wedge-shaped, with its base at the organ capsule and apex directed toward the hilum. Similar findings occur in splenic, renal, hepatic, and testicular infarction (Figure 1).2,3,11 In paired organs such as the kidney or testis, comparison with the contralateral side provides a useful internal control.

Conventional focused assessment with sonography in trauma (FAST) primarily detects free intraperitoneal fluid, which is an indirect sign of abdominal injury and may be absent despite parenchymal injury. Traumatic solid-organ injuries follow the same perfusion principle. Lacerations, hematomas, and devascularized segments appear as focal nonenhancing regions that may be occult on conventional B-mode imaging (Figure 2). In an early prospective series of CT-confirmed hepatic, splenic, and renal injuries, noncontrast sonography detected 50% of injuries compared with 91% using CEUS.12 More recent prospective point-of-care data similarly showed sensitivity improving from 65% to 94%, and a meta-analysis found pooled sensitivity increasing from 56% to 93% when CEUS was added (Table 2).13,14

| Modality | Sensitivity for Solid-Organ Injury | Ionizing Radiation | Nephrotoxicity/Creatinine | Serial Monitoring | Key Trauma Limitation |
|---|---|---|---|---|---|
| Conventional US/FAST | 56% (pooled)13 | None | No | Yes | Low sensitivity; free fluid as surrogate marker13 |
| CEUS | 93% (pooled)13 | None | No | Yes | Hollow viscus and mesentery; pancreas and adrenal glands; renal collecting system |
| Contrast-enhanced CT | Reference standard13 | Yes | Yes | Limited (cumulative dose) | Radiation; transport out of the resuscitation area |
Follow-up of a known injury is when CEUS can be particularly useful. The examination can be repeated without ionizing radiation and enables bedside assessment of evolving perfusion abnormalities, making it well-suited to contemporary nonoperative management strategies, especially in children (Table 2). Current trauma guidelines recognize CEUS as an alternative to CT for follow-up, including surveillance after splenic injury.15
Misdirected Perfusion: Extravascular Contrast and Active Hemorrhage
Active hemorrhage appears on CEUS as focal microbubble extravasation with progressive pooling or dispersion outside the expected vascular boundaries (Figure 3). Because microbubbles remain strictly intravascular, contrast outside a vessel is always abnormal. CEUS allows direct real-time visualization of hemorrhage as it evolves, providing temporal information that cannot be obtained from discrete CT contrast-enhancement phases alone.16 Potential applications include blunt or penetrating trauma, postprocedural bleeding, spontaneous hemorrhage, and vascular complications such as pseudoaneurysms.

Free Contrast in the Peritoneum
Microbubbles reaching the peritoneal cavity appear as free-floating echogenic foci within otherwise anechoic fluid, converting the nonspecific free fluid of the FAST exam into direct evidence of active bleeding (Figure 3). This principle underlies the contrast-enhanced FAST examination and substantially improves the detection of active hemorrhage compared with conventional US.13,17
Pooling within a Hematoma
Active bleeding within a hematoma appears as progressive contrast accumulation within the collection (Figure 3). CEUS demonstrates this process continuously following a single contrast injection and may help characterize a focal arterial source versus slower or indeterminate bleeding.18-20 CEUS can also guide treatment by identifying the bleeding source, confirming hemostasis after compression, or assessing whether percutaneous thrombin injection was effective.20
Pseudoaneurysm
Pseudoaneurysms represent a distinct form of extravascular contrast. Rather than accumulating progressively, they demonstrate cyclical filling and emptying with the cardiac cycle (Figure 3). Distinguishing pseudoaneurysm from active extravasation is clinically important because management can differ substantially.21 In children with blunt liver or splenic injuries, CEUS identified pseudoaneurysms with 83% sensitivity and 92% specificity.22 Post-traumatic pseudoaneurysms are an important target of follow-up imaging after nonoperative liver or splenic injury.15,22
Increased Perfusion: Infection and Inflammation
Inflamed tissue enhances earlier, more intensely, and for longer than surrounding parenchyma, reflecting vasodilation, capillary recruitment, and increased microvascular flow. Unlike ischemia, where the key finding is absent enhancement, inflammatory processes are characterized by relative hyperenhancement that can be assessed qualitatively or quantified using time-intensity curves.
Infection
Conventional US remains the first-line imaging modality for suspected acute cholecystitis; established findings include gallstones, wall thickening, pericholecystic fluid, and a sonographic Murphy sign. Currently, CEUS should not be positioned as a replacement for these criteria in routine uncomplicated disease. Its better-supported role is characterization of mural perfusion when complicated or gangrenous cholecystitis is suspected. In a prospective study of 150 surgically treated patients, focal or diffuse defects in gallbladder wall enhancement were associated with gangrenous cholecystitis, with reported sensitivity ranging from 85% to 91% and specificity ranging from 67.5% to 84.8%.23,24
Inflammation can produce early, intense mural enhancement, whereas progressive ischemia and necrosis produce focal or diffuse nonenhancement.23,24 The illustrative case below of acute acalculous cholecystitis demonstrates how inflammatory hyperemia and focal hypoperfusion can coexist within the same gallbladder wall as disease evolves.
Inflammation
In inflammatory bowel disease, CEUS allows direct assessment of bowel wall vascularity and disease activity.2 Active inflammation appears as early, intense mural enhancement, and enhancement measures correlate with endoscopic and clinical activity.25,26
At the point of care, its clearest role is assessment of known disease activity and complications rather than replacement of CT for an undifferentiated acute abdomen. In the terminal ileal stricture shown in Figure 4, near-transmural hyperenhancement supports persistent inflammatory activity despite chronic luminal narrowing. Because patients with inflammatory bowel disease often undergo repeated imaging over many years, CEUS also offers a radiation-free option for longitudinal assessment.26

Illustrative Case: Acute Acalculous Cholecystitis
A patient in her 80s receiving chemotherapy for locally advanced duodenal adenocarcinoma presented after a fall with weakness, confusion, nausea, and new right upper quadrant pain. Leukocyte count and liver biochemical test results were normal. Cross-sectional imaging showed gallbladder wall thickening and pericholecystic fluid without gallstones. Conventional US remained equivocal, showing a distended gallbladder with a 7 mm wall, trace pericholecystic fluid, no cholelithiasis, and an absent sonographic Murphy sign (Figure 5).

CEUS demonstrated intense mucosal hyperenhancement with focal nonenhancing regions within the thickened gallbladder wall (Figure 5), indicating inflammatory hyperemia with superimposed mural hypoperfusion. The wall remained intact, with no imaging evidence of perforation. In the clinical context, the findings supported acute acalculous cholecystitis and raised concern for evolving ischemic injury rather than uncomplicated inflammation.
This case illustrates that the 3 perfusion patterns described in this review are not fixed diagnostic categories. As acute disease evolves, inflammatory hyperemia, ischemia, and tissue injury may coexist within the same organ. By offering real-time assessment of tissue vascularity, CEUS can depict this transition directly and identify patients progressing from inflammation toward ischemia and necrosis.
Beyond the Abdomen: Additional Point-of-Care Applications
The perfusion principles described above extend beyond the abdominal organs and have been incorporated into emergency and critical care CEUS guidelines.27 In echocardiography, microbubble contrast improves endocardial border definition and left ventricular opacification in technically limited studies, particularly in critically ill patients. At the same time, myocardial perfusion imaging may provide additional information in patients with suspected ischemia.28,29
The same perfusion framework is applicable to vascular and thoracic imaging. In the aorta, CEUS can demonstrate contrast extravasation and is commonly used to detect endoleaks following endovascular aneurysm repair.2 In the lung, homogeneous enhancement of a peripheral consolidation favors infection, whereas absent or heterogeneous enhancement suggests pulmonary infarction from pulmonary embolism.30,31
Although these applications remain less established than abdominal CEUS, each reflects the same underlying approach: assessment of tissue perfusion and vascular integrity at the bedside.
CEUS also has a practical role in interventional radiology. It can improve visualization of targets that are inconspicuous on B-mode imaging, direct biopsy toward viable enhancing tissue and away from necrosis, guide and immediately assess ablation, identify postprocedural bleeding, and, with intracavitary administration, confirm catheter position or delineate cavities and fistulous tracts.32,33
Which Patients Benefit Most?
The advantages of CEUS are most apparent in clinical situations where repeated imaging, radiation, or iodinated contrast become important considerations. US contrast agents (UCAs) have an excellent safety profile, with severe adverse reactions reported in only 0.006% of adults and 0.016% of children.34 These rates are comparable to or lower than those associated with iodinated CT contrast and gadolinium-based MRI contrast agents.4
The potential advantages of CEUS are particularly relevant in several patient populations. Children often require serial imaging and are more vulnerable to cumulative radiation exposure. Patients with renal impairment or a history of adverse reactions to iodinated contrast may benefit from a perfusion study that does not require nephrotoxic contrast agents. Early experience in pregnancy has also been reassuring, although use remains off-label in the United States.8,35
The choice of imaging modality ultimately depends on the clinical question, target organ, acoustic window, and local expertise. However, the combination of real-time perfusion imaging, ready repeatability, lack of ionizing radiation, and bedside availability can make CEUS a preferred imaging strategy rather than merely an alternative to CT.
Integration into Acute and Point-of-Care Imaging Practice
Adding CEUS to an existing point-of-care practice is a logistical rather than a technical problem. The essential requirements are a US system with contrast-specific imaging capability, access to an approved UCA, IV access, and personnel familiar with contrast administration and image acquisition.7,36 Contrast-specific imaging is now available on many portable and mid-range US platforms, making implementation increasingly feasible in emergency departments and intensive care units.1,7,27,36
Clinical adoption is increasing but remains uneven, and robust national utilization data that permit direct comparison between the United States and other countries are limited. In a 2017 Society for Pediatric Radiology survey, 44 of 325 respondents (13.5%) reported performing pediatric CEUS. Of the respondents, 72% reported barriers, most commonly a lack of expertise, a lack of trained sonographers, time constraints, and uncertainty regarding reimbursement.37 A 2024 international survey of 454 younger radiologists from 48 countries found that 65.4% were aware of CEUS benefits, but 54.8% did not perform CEUS.38 The 2026 European Federation of Societies for Ultrasound in Medicine and Biology nonhepatic guideline update describes nonhepatic CEUS applications as steadily growing, with bowel imaging among active research areas and renal/urologic applications increasingly established in routine practice.39 These data are not directly comparable by country but emphasize recurring barriers: training, workflow, regulatory indications, access to contrast-specific software and agents, and reimbursement.
In the United States, however, most acute-care CEUS applications remain off-label because the commercially available UCAs are approved only for left ventricular opacification (Definity, Lumason, Optison), characterization of focal liver lesions (Lumason), and pediatric vesicoureteral reflux imaging (Lumason).8 Although this does not preclude clinical use, it should be reflected in institutional protocols and local consent practices.
Training for acute-care CEUS builds on existing US training and experience and does not require an entirely new skill set. Operators should already be proficient in the corresponding conventional examination and understand the enhancement characteristics associated with ischemia, hemorrhage, and inflammation.17 Structured reporting and archiving of cine clips are essential because interpretation depends on dynamic enhancement patterns, not isolated still images.
The principal limitations of CEUS are sonographic rather than pharmacologic. Body habitus, dressings, bowel gas, and limited acoustic windows may restrict image quality. CEUS also remains unreliable for hollow viscus and mesenteric injury and cannot evaluate structures that are not accessible sonographically.17
Whether CEUS is an adjunct to CT or the definitive study depends on the clinical question. CT remains the preferred imaging modality when injuries involve multiple organ systems or structures that cannot be adequately assessed with US. In contrast, CEUS may be the primary study for a defined set of indications: minor to moderate blunt abdominal trauma in stable children, follow-up of solid-organ injuries, active bleeding within accessible hematomas, and focused perfusion questions such as renal infarction or suspected complications of acute cholecystitis.3,13,17,18 In these settings, real-time bedside perfusion assessment can provide information that directly influences management.
Conclusion
Although modern imaging evaluates both structure and function, many acute-care questions are ultimately questions of tissue perfusion. CEUS provides real-time assessment of tissue perfusion at the bedside, a physiologic parameter that is often central to acute clinical decision-making. Across a broad range of acute and emergency conditions, CEUS findings can be interpreted using 3 recurring patterns: reduced perfusion associated with ischemia and infarction, extravascular contrast associated with active hemorrhage, and increased perfusion associated with inflammation and infection.
The evidence base is not uniform across indications. Trauma, solid-organ injury surveillance, active bleeding, and selected vascular complications are among the most mature acute-care applications, while inflammatory applications are more indication-specific and should be interpreted within conventional diagnostic pathways. The gallbladder case illustrates why the 3 perfusion patterns should not be viewed as fixed categories—inflammatory hyperemia and ischemic injury may coexist as a disease evolves.
For radiologists and acute-care clinicians, CEUS extends the diagnostic capabilities of conventional US without sacrificing portability or increasing radiation exposure. Although CT continues to be essential for comprehensive evaluation and pathology beyond the sonographic field of view, CEUS may serve as a complementary or, in selected settings, alternative imaging modality for pediatric trauma, follow-up of solid-organ injury, and assessment of accessible hemorrhagic, ischemic, and inflammatory processes.
CEUS provides direct assessment of tissue perfusion at the bedside, offering a practical way to answer important diagnostic questions in acute and emergent care.






